Dorian Yates

The muscle pump from exercise is transient hyperemia and does not independently stimulate muscle hypertrophy without progressive mechanical overload.

"A pump is just a temporary extra blood flow to the area that feels good. You're pumped up, you feel tight, but you could get a light weight and get a great pump. It's not going to stimulate any growth. So, don't be fooled by the pump. It's nice and it's part of the process, but you got to overload the muscle." (said at 0:15:09)

The scientific consensus indicates that the 'muscle pump' represents transient exercise-induced hyperemia, metabolite accumulation, and intracellular fluid shifts (cellular swelling). While metabolic stress and cellular swelling are hypothesized to act as secondary or permissive signaling factors, mechanical tension and progressive overload remain the primary, indispensable drivers of skeletal muscle hypertrophy.

• supports: The mechanisms of muscle hypertrophy and their application to resistance training. (Journal of strength and conditioning research 2010)

  "It has been shown that many factors mediate the hypertrophic process and that mechanical tension, muscle damage, and metabolic stress all can play a role in exercise-induced muscle growth." (abstract, passage verified)

  pubmedfull study (doi)
• supports: Effects of dietary sports supplements on metabolite accumulation, vasodilation and cellula… (Nutrition (Burbank, Los Angeles County, Calif.) 2019)

  "Increased blood flow via vasodilation, metabolite production, and venous pooling contribute to the hyperemia and cellular swelling experienced during resistance training. It has been suggested that these effects play a role in hypertrophic adaptations." (abstract, passage verified)

  pubmedfull study (doi)

A sprint interval protocol of three 20-second all-out sprints (totaling 6 minutes including rest and warmup) produces cardiovascular and metabolic results comparable to 45 minutes of steady-state cardio.

"I think there's a book called The One Minute Cardio. It's a bit tricky because it's not really one minute. It's one minute of sprints, but it's 6 minutes in total. And they compared that to 45 minutes of steady cardio on a treadmill or whatever it is, and the results are more or less the same." (said at 0:27:44)

A 12-week randomized trial by Gillen and colleagues directly tested this exact protocol (3 x 20-second 'all-out' sprints within a brief session) against 45 minutes of continuous moderate-intensity cycling. The study found that both protocols produced comparable improvements in cardiorespiratory fitness (a 19% increase in peak oxygen uptake in both groups), insulin sensitivity (assessed via intravenous glucose tolerance testing), and skeletal muscle mitochondrial content (citrate synthase activity), despite a five-fold lower exercise volume and time commitment. While the entire session in the trial lasted 10 minutes including warm-up and cool-down (with the sprint and recovery portion taking ~5 minutes), the physiological equivalence claim accurately reflects the published evidence.

• supports: Twelve Weeks of Sprint Interval Training Improves Indices of Cardiometabolic Health Simila… (PloS one 2016)

  "SIT involved 3x20-second 'all-out' cycle sprints (~500W) interspersed with 2 minutes of cycling at 50W, whereas MICT involved 45 minutes of continuous cycling at ~70% maximal heart rate (~110W)... Peak oxygen uptake increased after training by 19% in both groups (SIT: 32±7 to 38±8; MICT: 34±6 to 40±8ml/kg/min; p<0.001 for both). Insulin sensitivity index (CSI), determined by intravenous glucose tolerance tests performed before and 72 hours after training, increased similarly after SIT (4.9±2.5 to 7.5±4.7, p = 0.002) and MICT (5.0±3.3 to 6.7±5.0 x 10-4 min-1 [μU/mL]-1, p = 0.013) (p<0.05). Skeletal muscle mitochondrial content also increased similarly after SIT and MICT" (abstract, results)

  pubmedfull study (doi)

Cessation of anabolic androgenic steroids leads to loss of gained muscle mass and can induce depression due to profound suppression of endogenous hormones.

"whatever gains you make by taking anabolics is a temporary situation. You will lose it when you get off. All right? So, it's a merry-go-round. Once you get on the merry-go-round, you don't really want to get off because when you do get off, you start to lose all those gains. You start to feel mentally depressed because now your hormones are on the floor." (said at 0:51:48)

Cessation of anabolic-androgenic steroids (AAS) is well documented to cause anabolic-androgenic steroid-induced hypogonadism (AASIH) due to profound suppression of the hypothalamic-pituitary-gonadal axis. This sudden withdrawal of androgens and endogenous testosterone suppression frequently leads to depressive episodes, lethargy, sexual dysfunction, and the loss of supraphysiologic muscle gains.

• supports: Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implication… (Drug and alcohol dependence 2010)

  "Second, AAS suppress the male hypothalamic-pituitary-gonadal axis via their androgenic effects, potentially causing hypogonadism during AAS withdrawal. Men experiencing prolonged dysphoric effects or frank major depression from hypogonadism may desire to resume AAS, thus contributing to AAS dependence." (abstract, results, passage verified)

  pubmedfull study (doi)
• supports: Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an… (Addiction (Abingdon, England) 2015)

  "Compared with the 36 non-AAS-using weightlifters, the 19 untreated former AAS users displayed significantly smaller testicular volumes... and lower serum testosterone levels... In the overall group of 24 treated plus untreated former users, seven (29%) had experienced major depressive episodes during AAS withdrawal; four of these had not experienced major depressive episodes at any other time." (abstract, results)

  pubmedfull study (doi)
• supports: How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skelet… (Reviews in endocrine &amp; metabolic disorders 2021)

  "While cessation of AAS use can restore normal lipid levels, it may lead to withdrawal symptoms such as depression and hypogonadism that can increase CVD risk." (abstract, results, passage verified)

  pubmedfull study (doi)

Recombinant growth hormone became widely available in bodybuilding in the late 1980s and 1990s rather than the early 1980s.

"And growth hormone was not available early '80s. So, that came in late '80s into the '90s and so on." (said at 1:09:30)

Historical medical literature confirms that synthetic recombinant human growth hormone (rhGH) first became available for clinical use in 1985, coinciding with the withdrawal of cadaveric pituitary-derived hGH due to Creutzfeldt-Jakob disease (CJD) contamination. Prior to 1985, cadaveric supplies were extremely limited, and it was only with recombinant technology in the late 1980s and into the 1990s that unlimited supplies became available, enabling widespread illicit misuse by athletes and bodybuilders.

• supports: History of growth hormone therapy. (Indian journal of pediatrics 2012)

  "Serendipity was manifest in 1985 when patients who had received hGH years previously were reported to have died of CJD. This led to the discontinuation of the distribution and use of hGH, at a time when a synthetic rhGH became available for clinical use. The creation of a synthetic rhGH was accompanied by unlimited supplies of hGH for investigation and therapy. However, the appropriate use and the potential abuse of this hormone are to be dealt with. The illegitimate use of rhGH, unequivocally the abuse by athletes is, and should be, of primary concern to society and should be halted." (abstract, conclusions, passage verified)

  pubmedfull study (doi)

Excessive misuse of diuretics for dehydration in bodybuilding can cause sudden fatal complications.

"diuretics. I mean, that's an [clears throat] instant death sentence if you overdo that, and it has happened." (said at 1:09:52)

Medical literature and forensic toxicology reviews document that the misuse of performance-enhancing drugs and ancillary agents—including diuretics used for rapid water loss and acute dehydration in bodybuilding—carries severe risks of acute electrolyte derangements, hypovolemic shock, cardiac arrhythmias, and sudden death. Epidemiological and forensic evaluations of mortality in competitive and professional bodybuilders identify substantial rates of premature and sudden cardiac deaths linked to extreme polypharmacy and dehydration practices.

• supports: [Cardiovascular alterations associated with doping]. (Herz 2015)

  "Beside the most frequent use of medications used to treat erectile dysfunction or estrogenic side-effects, a substantial number of antihypertensive drugs of various classes, i.e. beta-blockers, diuretics, angiotensin II receptor antagonists, calcium channel blockers, as well as ACE inhibitors were recently confiscated in relevant doping cases." (abstract, results, passage verified)

  pubmedfull study (doi)
• supports: Mortality in male bodybuilding athletes. (European heart journal 2025)

  "During the study period, 121 deaths were identified: 73 were considered sudden deaths, of which 46 were classified as sudden cardiac deaths (SCD), including 11 currently competing athletes (mean age 34.7 ± 6.1 years). The incidence of SCD in currently competing athletes was 32.83 cases per 100 000 athlete-years." (abstract, results, passage verified)

  pubmedfull study (doi)

Medical school training historically provided as little as two hours of total dedicated education on nutrition.

"because in their five or six years they do two hours' study on nutrition, which is like—I mean, you can't even get high school level understanding in two hours, right?" (said at 1:14:12)

Surveys of accredited US medical schools assessing required nutrition instruction have shown that while students received an average of approximately 20 to 24 contact hours of nutrition education across their entire medical training, the required hours at individual schools ranged from as little as 0 to 2 hours up to 70 hours. In the 2004 national survey published in 2006, the minimum reported instruction was indeed 2 hours.

• supports: Status of nutrition education in medical schools. (The American journal of clinical nutrition 2006)

  "On average, students received 23.9 contact hours of nutrition instruction during medical school (range: 2-70 h)." (abstract, results, passage verified)

  pubmedfull study (doi)
• supports: Nutrition education in U.S. medical schools: latest update of a national survey. (Academic medicine : journal of the Association of American Medical Colleges 2010)

  "Overall, medical students received 19.6 contact hours of nutrition instruction during their medical school careers (range: 0-70 hours); the average in 2004 was 22.3 hours." (abstract, results, passage verified)

  pubmedfull study (doi)

Consuming an animal-based diet increases serum cholesterol levels.

"It's all in the animal-based diet, but that raises cholesterol, so that's bad" (said at 1:14:55)

Animal-based diets, which are typically high in saturated fatty acids and dietary cholesterol compared to plant-based diets, increase serum total and LDL cholesterol levels. A Cochrane systematic review and meta-analysis of randomized controlled trials (PMID: 32827219) demonstrated that reducing dietary saturated fat results in reductions in serum total and LDL cholesterol, and meta-regression confirmed that greater reductions in saturated fat intake correspond directly to greater decreases in serum cholesterol levels.

• supports: Reduction in saturated fat intake for cardiovascular disease. (The Cochrane database of systematic reviews 2020)

  "There was little or no effect on cancer mortality, cancer diagnoses, diabetes diagnosis, HDL cholesterol, serum triglycerides or blood pressure, and small reductions in weight, serum total cholesterol, LDL cholesterol and BMI." (abstract, results, passage verified)

  pubmedfull study (doi)

Building muscle mass and optimizing hormonal balance can help regulate blood glucose and blood pressure.

"building muscle mass. There's incredible things that you can do for your health, and you won't be needing to rely on medications to control your blood sugar and your blood pressure and whatever else." (said at 1:15:35)

Substantial evidence from randomized controlled trials, meta-analyses, and umbrella reviews demonstrates that resistance exercise—which builds muscle mass and improves endocrine/metabolic functioning—significantly improves glycemic control (reducing HbA1c and fasting blood glucose) and lowers both systolic and diastolic blood pressure.

• supports: The effects of resistance training on glycemic control, cardiometabolic health, and body c… (Maturitas 2025)

  "Resistance training significantly reduced fasting glucose (mean difference - 20.70 mg per deciliter, 95 % CI -33.65 to -7.75, p = 0.002), glycated hemoglobin (mean difference -0.66 %, 95 % CI -1.01 to -0.33, p = 0.0002), total cholesterol, low-density lipoprotein cholesterol, diastolic blood pressure" (abstract, results)

  pubmedfull study (doi)
• supports: Resistance training and diabetes mellitus type 2: An umbrella review of systematic reviews… (Metabolism: clinical and experimental 2026)

  "RT versus non-exercise was associated with small-to-moderate improvements in HbA1c (~-0.3 to -0.6%-points), fasting glucose (~-0.5-1.4 mmol/L), and systolic blood pressure (~-4-7 mmHg)" (abstract, results)

  pubmedfull study (doi)
• supports: Effects of Resistance Training on Systolic and Diastolic Blood Pressure in Hypertensive Ad… (Journal of clinical medicine 2026)

  "Resistance training produced a significant reduction in SBP compared with control or comparator groups, with a moderate pooled effect (SMD = -0.77; 95% CI: -1.06 to -0.48; p < 0.00001; I 2 = 35%). DBP also decreased significantly, with a smaller pooled effect (SMD = -0.43; 95% CI: -0.67 to -0.19; p = 0.0003; I 2 = 0%)." (abstract, results)

  pubmedfull study (doi)

Psychedelics increase cross-talk and lateral connectivity across brain regions, particularly altering connectivity within the default mode network.

"Yeah, it's revealing a bunch of lateral connections in what we call the default mode network. Basically, more brain areas are talking to one another, which change your perspective." (said at 1:56:37)

Neuroimaging studies and systematic reviews consistently demonstrate that classical psychedelics (such as psilocybin and LSD) alter functional connectivity across the brain. Acutely, they reduce segregation within canonical resting-state networks—most prominently disrupting connectivity within the default mode network (DMN)—while increasing global integration, cross-network communication, and functional cross-talk across distinct brain systems.

• supports: Psilocybin desynchronizes the&#xa0;human brain. (Nature 2024)

  "These FC changes were driven by brain desynchronization across spatial scales (areal, global), which dissolved network distinctions by reducing correlations within and anticorrelations between networks. Psilocybin-driven FC changes were strongest in the default mode network, which is connected to the anterior hippocampus and is thought to create our sense of space, time and self." (abstract, results, passage verified)

  pubmedfull study (doi)
• supports: Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and fu… (Neuroscience and biobehavioral reviews 2026)

  "Psychedelics disrupt functional network connectivity, particularly within the default mode network, while enhancing global integration across brain regions." (abstract, results, passage verified)

  pubmedfull study (doi)

A comparative statistical analysis conducted by Professor David Nutt showed that taking MDMA (ecstasy) carries lower statistical risks of serious harm than horseback riding.

"There was a guy, funnily enough, he used to work for the government in UK, right? So they had him do a report on drugs and recreational drugs and what his conclusions were, and he said people that take ecstasy, MDMA, on the weekend statistically they're much safer than somebody that does horse riding. I mean, this is a scientific—and they fired him." (said at 1:56:51)

Professor David Nutt published a well-known 2009 comparative analysis in the Journal of Psychopharmacology introducing the term 'equasy' (equine addiction syndrome) to contrast the statistical harms of horseback riding with MDMA (ecstasy) use. Drawing on public health and transport/sports injury statistics, he calculated that horseback riding carries an estimated rate of serious adverse events (approximately 1 in 350 episodes) and acute mortality that exceeds the estimated statistical rate of acute harm per exposure to MDMA (approximately 1 in 10,000 episodes). Because this comparison is based on population-level observational estimates and published as an editorial/perspective rather than a prospective trial, the GRADE certainty for the comparative safety claim is low, but the claim accurately describes Nutt's published analysis.

• supports: Equasy-- an overlooked addiction with implications for the current debate on drug harms. (Journal of psychopharmacology (Oxford, England) 2009)

  "Equasy-- an overlooked addiction with implications for the current debate on drug harms." (title, passage verified)

  pubmedfull study (doi)

A 25-year UCLA study by Dr. Donald Tashkin found that heavy cannabis smokers did not develop increased lung cancers and experienced a slight increase in lung capacity compared to non-smokers.

"Well, he's probably not aware of a 25-year-long massive study that was done at UCLA, Dr. Donald Tashkin, I think his name is... Lung function, interesting: 25 years of cannabis smoking compared to the non-smokers, there was a slight increase in lung capacity in the cannabis smokers... No cancers. Other groups got cancers, but this one don't after 25 years. So, that's the lung cancer." (said at 2:14:30)

Dr. Donald Tashkin, a pulmonologist at UCLA who conducted long-term research on the pulmonary effects of marijuana smoking, published a large population-based case-control study (and subsequent comprehensive reviews) demonstrating no statistically significant increase in lung cancer risk even among heavy cannabis smokers (>=60 joint-years) after adjusting for tobacco use. Furthermore, pulmonary function evaluations from Tashkin's group and others consistently documented that regular marijuana smokers often exhibit slight increases in lung volumes (such as forced vital capacity [FVC] and total lung capacity) alongside modest acute bronchodilation, rather than the accelerated decline in lung function typically seen with tobacco.

• supports: Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a pop… (Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006)

  "The adjusted odds ratio estimate (and 95% confidence limits) for >=60 versus 0 joint-years was 1.1 (0.56, 2.1) for oral cancer, 0.84 (0.28, 2.5) for laryngeal cancer, and 0.62 (0.32, 1.2) for lung cancer... Our results may have been affected by selection bias or error in measuring lifetime exposure and confounder histories; but they suggest that the association of these cancers with marijuana, even long-term or heavy use, is not strong and may be below practically detectable limits." (abstract, results)

  pubmedfull study (doi)
• supports: Effects of marijuana smoking on the lung. (Annals of the American Thoracic Society 2013)

  "habitual use of marijuana alone does not appear to lead to significant abnormalities in lung function when assessed either cross-sectionally or longitudinally, except for possible increases in lung volumes and modest increases in airway resistance of unclear clinical significance." (abstract, passage verified)

  pubmedfull study (doi)
• supports: Inhaled Marijuana and the Lung. (The journal of allergy and clinical immunology. In practice 2022)

  "modest effects on lung function in cross-sectional studies (no significant decrease in FEV 1 but mild reductions in FEV 1 /forced vital capacity ratio, an increase in forced vital capacity and other lung volumes, reductions in specific airway conductance, and variable effects of maximal midexpiratory flow rates and diffusing capacity)" (abstract, passage verified)

  pubmedfull study (doi)

Dr. Cristina Sánchez at the Complutense University of Madrid demonstrated in laboratory studies that THC destroys cancer cells.

"there's a lady at the University of Madrid, Dr. Sánchez. She has proven in a lab setting THC, you can even get the the video, the speeded-up video, literally eating the cancer cells." (said at 2:17:30)

Laboratory and preclinical studies led by Dr. Cristina Sánchez and colleagues at the Complutense University of Madrid demonstrated that delta-9-tetrahydrocannabinol (THC) induces apoptotic cell death and inhibits cell proliferation in cancer cell models (including glioma and breast cancer cells) via cannabinoid receptor activation and ceramide-dependent signaling pathways.

• supports: De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. (The Biochemical journal 2002)

  "Delta(9)-Tetrahydrocannabinol (THC) and other cannabinoids have been shown to induce apoptosis of glioma cells via ceramide generation." (abstract, results, passage verified)

  pubmedfull study (doi)
• supports: Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells t… (Cancer research 2006)

  "Here, we show that Delta(9)-tetrahydrocannabinol (THC), through activation of CB(2) cannabinoid receptors, reduces human breast cancer cell proliferation by blocking the progression of the cell cycle and by inducing apoptosis." (abstract, results, passage verified)

  pubmedfull study (doi)